Back to search results

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Stanford Cancer Institute, Stanford, California, United States

    Contact: Study coordinator (Nana Shakhnazaryan) · nshakhna@stanford.edu · 650-304-9443

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Molly Dubois, Sr. Clinical Research Coordinator) · amalia@wustl.edu · 314-273-1486

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Catherine Maccaro) · maccaroc@mskcc.org · 646-608-2883

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

    Contact: Study coordinator (AskSarah Help Line) · 844-482-4812

  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Kerry Savage) · ksavage@bccancer.bc.ca · 604-877-6000
View source on ClinicalTrials.gov(opens in a new tab)